The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 72 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Colorectal Neoplasms  [Clear All Filters]
2010
Kanellos, D., Pramateftakis M. G., & Kanellos I. (2010).  Standardization and time trends in laparoscopic colorectal surgery.. Surg Endosc. 24(3), 726-7.
2011
Giouleme, O., Diamantidis M. D., & Katsaros M. G. (2011).  Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.. World J Gastroenterol. 17(4), 444-8.
Eaton, J. E., Silveira M. G., Pardi D. S., Sinakos E., Kowdley K. V., Luketic V. A. C., et al. (2011).  High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.. Am J Gastroenterol. 106(9), 1638-45.
Spanos, C. P., Tsoulfas G., Georgantis G., Melas N., Saratzis N., Ktenidis K., et al. (2011).  Management of concurrent colorectal cancer and vascular disease in the endovascular era.. Tech Coloproctol. 15 Suppl 1, S55-8.
Linsky, A., McIntosh N., Cabral H., & Kazis L. E. (2011).  Patient-provider language concordance and colorectal cancer screening.. J Gen Intern Med. 26(2), 142-7.
2012
Kapetanos, D., Beltsis A., Chatzimavroudis G., & Katsinelos P. (2012).  Postpolypectomy bleeding: incidence, risk factors, prevention, and management.. Surg Laparosc Endosc Percutan Tech. 22(2), 102-7.
Scatton, O., Katsanos G., & Soubrane O. (2012).  Two-stage hepatectomy: tape it and hang it, while you can.. World J Surg. 36(7), 1647-50.
Koutras, A. K., Antonacopoulou A. G., Eleftheraki A. G., Dimitrakopoulos F-I., Koumarianou A., Varthalitis I., et al. (2012).  Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab.. Pharmacogenomics J. 12(6), 468-75.
Pectasides, D., Papaxoinis G., Kalogeras K. T., Eleftheraki A. G., Xanthakis I., Makatsoris T., et al. (2012).  XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.. BMC Cancer. 12, 271.
2013
Pentheroudakis, G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., Makatsoris T., et al. (2013).  Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.. BMC Cancer. 13, 49.
Martin, V., Landi L., Molinari F., Fountzilas G., Geva R., Riva A., et al. (2013).  HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients.. Br J Cancer. 108(3), 668-75.
Kountouras, J., Kapetanakis N., Zavos C., Romiopoulos I., Polyzos S. A., Tsiaousi E., et al. (2013).  Impact of Helicobacter pylori Infection on colon oncogenesis.. Am J Gastroenterol. 108(4), 625-6.
Strimpakos, A., Pentheroudakis G., Kotoula V., De Roock W., Kouvatseas G., Papakostas P., et al. (2013).  The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.. Clin Colorectal Cancer. 12(4), 267-274.e2.
Kamposioras, K., Konstantara A., Kotoula V., Lakis S., Kouvatseas G., Akriviadis E., et al. (2013).  The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.. Anticancer Res. 33(10), 4573-84.
Hyphantis, T., Papadimitriou I., Petrakis D., Fountzilas G., Repana D., Assimakopoulos K., et al. (2013).  Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.. Psychooncology. 22(9), 2009-15.
Pavlidis, E. T., & Pavlidis T. E. (2013).  Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.. World J Gastroenterol. 19(31), 5051-60.
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Lanitis S., Konstantinou C., et al. (2013).  The value of plasma neurotensin and cytokine measurement for the detection of bowel ischaemia in clinically doubtful cases: a prospective study.. Exp Biol Med (Maywood). 238(8), 874-80.
2014
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Kouklakis G., Venizelos I., et al. (2014).  Active Helicobacter pylori infection is associated with colorectal mucosa-adenomatous polyp--early and advanced adenocarcinoma sequence.. Scand J Gastroenterol. 49(3), 381-2.
Evrard, S., Poston G., Kissmeyer-Nielsen P., Diallo A., Desolneux G., Brouste V., et al. (2014).  Combined ablation and resection (CARe) as an effective parenchymal sparing treatment for extensive colorectal liver metastases.. PLoS One. 9(12), e114404.
Sgourakis, G., Papapanagiotou A., Kontovounisios C., Karamouzis M. V., Dedemadi G., Goumas C., et al. (2014).  The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer.. Tumour Biol. 35(6), 5993-6002.
Razis, E., Pentheroudakis G., Rigakos G., Bobos M., Kouvatseas G., Tzaida O., et al. (2014).  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.. J Cancer Res Clin Oncol. 140(5), 737-48.
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Romiopoulos, I., Kountouras J., Polyzos S. A., Zavos C., Kapetanakis N., Deretzi G., et al. (2014).  Helicobacter pylori-related metabolic syndrome might justify earlier colorectal cancer screening.. Gastrointest Endosc. 80(1), 188-9.
Dermitzakis, E. V., Kimiskidis V. K., Eleftheraki A., Lazaridis G., Konstantis A., Basdanis G., et al. (2014).  The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system.. Eur J Neurol. 21(12), 1471-7.
Krikelis, D., Skoura E., Kotoula V., Rondogianni P., Pianou N., Samartzis A., et al. (2014).  Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.. Anticancer Res. 34(5), 2571-9.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.